Latest Insider Transactions at Voyager Therapeutics, Inc. (VYGR)
This section provides a real-time view of insider transactions for Voyager Therapeutics, Inc. (VYGR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Voyager Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Voyager Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2023
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,188
-2.04%
|
$19,692
$9.96 P/Share
|
|
Jan 11
2023
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
110,000
-2.78%
|
$880,000
$8.5 P/Share
|
|
Jan 10
2023
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
336,400
-7.83%
|
$2,691,200
$8.05 P/Share
|
|
Jan 09
2023
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
456,000
-9.59%
|
$3,192,000
$7.67 P/Share
|
|
Jan 06
2023
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
388
-1.06%
|
$2,328
$6.41 P/Share
|
|
Dec 31
2022
|
Todd Alfred Carter Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
388
+1.05%
|
$1,940
$5.17 P/Share
|
|
Oct 01
2022
|
Peter P. Pfreundschuh Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+50.0%
|
-
|
|
Aug 25
2022
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-3.55%
|
$1,200,000
$6.22 P/Share
|
|
Aug 24
2022
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
149,972
-2.6%
|
$899,832
$6.09 P/Share
|
|
Aug 16
2022
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
128,456
-2.17%
|
$770,736
$6.04 P/Share
|
|
Aug 15
2022
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
135,808
-2.25%
|
$814,848
$6.04 P/Share
|
|
Aug 12
2022
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
348,007
-5.45%
|
$2,088,042
$6.12 P/Share
|
|
Jul 14
2022
|
Glenn Pierce Director |
SELL
Open market or private sale
|
Direct |
9,512
-36.17%
|
$57,072
$6.7 P/Share
|
|
Jul 14
2022
|
Michael J Higgins Director |
SELL
Open market or private sale
|
Direct |
13,891
-30.73%
|
$83,346
$6.7 P/Share
|
|
Jun 23
2022
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
376,000
+7.33%
|
$1,880,000
$5.66 P/Share
|
|
Jun 21
2022
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
101,400
+2.26%
|
$507,000
$5.28 P/Share
|
|
Apr 04
2022
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
2,786
-2.37%
|
$22,288
$8.25 P/Share
|
|
Apr 04
2022
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,527
-2.85%
|
$12,216
$8.25 P/Share
|
|
Mar 22
2022
|
Alfred Sandrock President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Mar 21
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
2,649
-2.4%
|
$21,192
$8.49 P/Share
|
|
Mar 21
2022
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
4,955
-2.02%
|
$39,640
$8.49 P/Share
|
|
Mar 21
2022
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,413
-3.81%
|
$35,304
$8.49 P/Share
|
|
Feb 17
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
789
-1.41%
|
$2,367
$3.55 P/Share
|
|
Feb 17
2022
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
4,100
-3.23%
|
$12,300
$3.55 P/Share
|
|
Feb 11
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
361
-0.64%
|
$1,083
$3.36 P/Share
|
|
Feb 11
2022
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,252
-2.5%
|
$9,756
$3.36 P/Share
|
|
Jan 13
2022
|
Michael J Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,205
+50.0%
|
-
|
|
Jan 13
2022
|
Glenn Pierce Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,300
+50.0%
|
-
|
|
Jan 13
2022
|
Robert W. Hesslein Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+13.33%
|
-
|
|
Jan 13
2022
|
Julie Burek VP, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+15.09%
|
-
|
|
Jan 12
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
265
-0.57%
|
$795
$3.06 P/Share
|
|
Jan 03
2022
|
Julie Burek VP, Finance |
SELL
Open market or private sale
|
Direct |
3,063
-6.18%
|
$6,126
$2.83 P/Share
|
|
Dec 31
2021
|
Julie Burek VP, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
3,063
+5.82%
|
$6,126
$2.3 P/Share
|
|
Nov 26
2021
|
Julie Burek VP, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+22.49%
|
-
|
|
May 21
2021
|
Omar Khwaja Officer |
SELL
Open market or private sale
|
Direct |
3,516
-2.83%
|
$14,064
$4.03 P/Share
|
|
Apr 05
2021
|
Robert W. Hesslein Senior VP & General Counsel |
BUY
Open market or private sale
|
Direct |
3,292
+2.9%
|
$13,168
$4.95 P/Share
|
|
Mar 19
2021
|
Allison Dorval Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+21.44%
|
-
|
|
Mar 19
2021
|
Andre Turenne President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+19.88%
|
-
|
|
Mar 19
2021
|
Robert W. Hesslein Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+20.93%
|
-
|
|
Mar 19
2021
|
Omar Khwaja Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+22.01%
|
-
|
|
Feb 16
2021
|
Allison Dorval Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+29.85%
|
-
|
|
Feb 16
2021
|
Robert W. Hesslein Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+28.97%
|
-
|
|
Feb 16
2021
|
Omar Khwaja Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+28.79%
|
-
|
|
Feb 16
2021
|
Andre Turenne President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
94,000
+27.95%
|
-
|
|
Feb 11
2021
|
Omar Khwaja Officer |
SELL
Open market or private sale
|
Direct |
3,475
-6.15%
|
$24,325
$7.55 P/Share
|
|
Feb 11
2021
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,186
-6.06%
|
$22,302
$7.55 P/Share
|
|
Feb 11
2021
|
Allison Dorval Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,186
-6.49%
|
$22,302
$7.55 P/Share
|
|
Feb 11
2021
|
Andre Turenne President & CEO |
SELL
Open market or private sale
|
Direct |
7,977
-5.1%
|
$55,839
$7.55 P/Share
|
|
Jan 12
2021
|
Allison Dorval Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,942
-5.66%
|
$23,536
$8.62 P/Share
|
|
Jan 12
2021
|
Andre Turenne President & CEO |
SELL
Open market or private sale
|
Direct |
10,443
-6.26%
|
$83,544
$8.62 P/Share
|